Anhui BBCA Pharmaceutical Co.,Ltd

About Anhui BBCA Pharmaceutical Co.,Ltd

BBCA PHARMA, a subsidiary of BBCA Group, is the first pharmaceutical listed company in Anhui province (It was listed in Shenzhen Stock Exchange in 2000 and the Stock Code is 000153). Established for almost 60 years, BBCA PHARMA has successively earned a reputation of China’s Top 100 Pharmaceutical Industries for several years since 2006. Integrating R&D, manufacturing with sales, BBCA PHARMA has developed into a national high and new tech enterprise, leading with large-volume transfusion (the annual amount is over 500 million bottles/bags) and assisting by analgesic-antipyretic, cardiovascular, antibiotic products, etc. 53 international production lines certified by GMP, its products include more than ten kinds of dosage forms and 300 varieties of drugs, involving fields of bio-pharmaceutical, chemical pharmaceutical, Chinese Herbal Medicine and APIs. Employing more than 5, 000 staff, the sales income of BBCA PHARMA has been over 3 billion. BBCA PHARMA owns and is the mother company of seven pharmaceutical factories（including the manufacture branch Anhui BBCA Likang Pharmaceutical Co., Ltd）, one National Pharmaceutical R&D Center, six pharmaceutical marketing companies and one pharmacy chain with more than 600 pharmacies. In which, the international business company mainly engage in exporting business of APIs and preparations, importing raw materials, equipment procurement and registration of drugs. Varieties of preparations have been registered and marketed in Myanmar, Vietnam, the Philippines, Uzbekistan, Pakistan, Nigeria, Ecuador, Cameroon and many other countries.